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 Clinical research on insomnia has observed that many individuals with this sleep 
disorder exhibit a significant discrepancy between their subjective reports of symptom 
severity and objective measures of the same parameters.  This study sought to more closely 
examine this discrepancy by comparing sleep diary estimates with polysomnography data in 
a population of 60 older adults with comorbid insomnia.  Consistent with previous research, 
results show that participants significantly underestimated sleep efficiency and total sleep 
time and significantly overestimated sleep onset latency.  Participants receiving CBT-I 
exhibited significantly reduced discrepancy at post-treatment, particularly with regard to 
sleep latency, compared to those in a Stress Management and Wellness treatment control 
group.  This suggests that the treatment effects observed as a result of CBT can be partly 
explained by improvements in the accuracy of sleep estimation.  Additionally, high 
discrepancy at baseline was found to be a significant predictor of positive treatment outcome, 
indicating that sleep misperception is a potential factor in a favorable treatment response to 
CBT.  
 
 1 
 
The discrepancy between subjective and objective measures of sleep in older adults  
receiving CBT for comorbid insomnia 
 
 Insomnia is a common sleep disorder characterized by a difficulty in initiating, 
maintaining, or obtaining sufficient good quality sleep that causes clinically significant 
distress or impairment in social, occupational, or other important areas of functioning.  
Prevalence estimates vary greatly but suggest that rates of insomnia in the general population 
may be as high as 10% to 15%, with 20% to 40% reporting some symptoms of disturbed 
sleep (Morin, LeBlanc, Daley, Gregoire, & Merette, 2006; Kiley, 1999).  Although sleep 
complaints of this nature are fairly common in most primary care settings and are often 
regarded as ancillary to other medical conditions, insomnia is a distinct disorder with serious 
implications that may negatively impact health and impair daily functioning (Gallup 
Organization, 1995; Dement & Pelayo, 1997; Ohayon, 1997; Simon & VonKorff, 1997).  
Chronic insufficient sleep has the potential to exacerbate existing health problems and may 
decrease quality of life in those whom it afflicts (Leger, Guilleminault, Bader, Levy, & 
Paillard, 2002).  Further evidence suggests that symptoms of insomnia may additionally 
contribute to increased health care costs and utilization, mental illness, work-related 
accidents, work absenteeism and reduced productivity, increased drug and alcohol use, and 
higher risk for mortality (Chang, Ford, & Mead, 1997; Livingston, Blizard & Mann, 1993; 
Vollrath, Wicki, & Angst, 1989; Kripke et al., 1998; Johnson & Spinweber, 1983; Edinger & 
Wohlgemuth, 1999). 
Insomnia that occurs independent of other medical conditions, most often referred to 
as Primary Insomnia, can be difficult to diagnose and treat, however these processes may be 
complicated further when symptoms of disturbed sleep accompany other medical or 
psychiatric conditions.  Formerly labeled Secondary Insomnia due to the original thought that 
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insomnia symptoms may occur as a direct consequence of or secondary to a separate medical 
or psychiatric disorder, a 2005 National Institutes of Health (NIH) State of the Science 
Conference statement suggested that this set of symptoms may be more accurately described 
by the term Comorbid Insomnia (NIH, 2005).  Stepanski and Rybarczyk (2006) suggest that 
the idea of cause and effect implied by the term Secondary Insomnia may be too simple to 
accurately reflect how insomnia relates to other existing conditions.  Although the prevailing 
treatment approach for insomnia comorbid with other conditions had been to focus the 
treatment on the primary medical or psychiatric problem, in the past decade treatment 
guidelines have shifted to behavioral treatment of insomnia as the first step in treatment, 
whether or not other conditions are present (Stepanski & Rybarczyk, 2006).  This 
demonstrates the growing recognition of insomnia as a distinct condition with serious 
implications for the physical and mental health of those who suffer from it, especially those 
with comorbid diagnoses.   
 Insomnia is of particular concern in the older adult population due to the fact that it is 
most common, severe, and impairing in adults over 60 years of age (Lichstein, Durrence, & 
Riedel, 2004; Morgan, 2000; Morphy, Dunn, & Lewis, 2007; Stewart, Besset, &Bebbington, 
2006).  Insomnia in older adults occurs more frequently in individuals with chronic medical 
conditions than in those who fall into the healthier segment of this population (Prinz, 
Williams, & Vitiello, 1990; Williams, Vitiello, Ries, Bokan, & Prinz, 1988).  It is estimated 
that comorbid insomnia may account for approximately 70% of insomnia cases in older 
adults (Lichstein, 2000).  Several common medical illnesses known to be connected with the 
aging process, including cardiovascular disease, pulmonary disease, and chronic pain 
conditions caused primarily by arthritis, have been strongly linked to high rates of insomnia 
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(Jordan et al., 2000; Katz & McHorney, 1998). 
 One observation in the clinical research that has emerged as a common characteristic 
of insomnia is the lack of a consistent relationship between subjective reports of sleep and 
objective measures such as polysomnography.  Numerous studies have found that a 
proportion of insomniacs report sleep problems without exhibiting objective proof of 
insomnia (Carskadon et al., 1976; Bixler, Kales, & Leo, 1973; Jacobs, Reynolds, Kupfer, 
Lovin, & Ehrenpreis, 1998; Frankel, Coursey, Buchbinder, & Snyder, 1976; Edinger & Fins, 
1995; Rosa & Bonnet, 2000; Vanable, Aikens, Tadimeti, Caruana-Montaldo, & Mendelson, 
1999; Chambers & Keller, 1993; Mercer, Bootzin, & Lack, 2002).  For others, objective 
measures do reflect problematic sleep but not to the extent that subjective reports suggest.  
This significant mismatch between individuals' subjective reports of insomnia symptoms and 
the objective measures of the specific sleep parameters used to identify them is a 
phenomenon that complicates the question of how to best define and measure insomnia and 
highlights the complexity and multidimensional nature of insomnia as a disorder.  This 
discrepancy also poses questions about how best to differentially treat insomnia in 
individuals who do versus do not report an exaggerated subjective impression of their 
symptoms.  
 These issues underscore the need for additional research that focuses specifically on 
the subjective/objective discrepancy in insomnia.  A better understanding of this 
phenomenon may inform our conceptualization and definition of insomnia and may increase 
our knowledge of what contributes to the development and maintenance of the disorder.  
These gains would inform insomnia research by assessing the accuracy of subjective 
measures of sleep, which are solely relied upon to determine criteria for an insomnia 
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diagnosis in 90% of clinical trials (Lichstein, Durrence, Taylor, Bush, & Riedel, 2003).  
Additionally, such gains would inform clinical treatment of insomnia by providing insight 
into what should be the primary targets for treatment.  Cognitive Behavioral Therapy for 
Insomnia (CBT-I) has been shown to reduce dysfunctional beliefs and attitudes about sleep 
as measured by the Dysfunctional Beliefs and Attitudes about Sleep (DBAS) scale, however 
the impact of CBT-I on the accuracy of subjective symptom reporting or the discrepancy 
between subjective and objective measures has not been closely examined (Edinger, 
Wohlgemuth, Radtke, Marsh, & Quillian, 2001).  Furthermore, it is unknown whether the 
size of the subjective/objective discrepancy is a predictor of treatment outcome. 
 Despite the high prevalence of insomnia in the older adult population, concentrated in 
those with comorbid conditions, few studies to date have examined the subjective/objective 
discrepancy in this specific population.  Research has identified this population to be at 
particular risk for making inaccurate subjective impressions of their insomnia symptoms due 
to a higher endorsement of unrealistic sleep expectations or worry over the effect of 
compromised sleep on daytime functioning (Morin, Stone, Trinkle, Mercer, & Remsberg, 
1993).  Additional research is needed to gain a clearer understanding of how these cognitions 
may relate to the discrepancy between subjective and objective measures of insomnia.  
Identifying cognitive and other correlates of this objective/subjective discrepancy among 
older adults may improve our understanding of the phenomenon. 
The purpose of the proposed study was to examine the discrepancy between 
subjective and objective measures of insomnia in a sample of 92 older adults who 
participated in a large randomized controlled intervention study for insomnia that co-
occurred with a diagnosis of osteoarthritis (OA), coronary artery disease (CAD) or/and 
 5 
 
chronic obstructive pulmonary disease (COPD).  Statistical analysis was used to determine 
whether there exists a significant discrepancy between subjective data collected using 
participant logs and objective data collected using polysomnography and to examine how this 
discrepancy might change following eight weeks of treatment with CBT-I as compared to a 
Stress Management and Wellness (SMW) treatment.  Analyses were also conducted to 
explore possible predictors of the subjective/objective discrepancy (specifically, the 
endorsement of dysfunctional beliefs and attitudes about sleep and mood or anxiety scores) 
and to examine the magnitude of the discrepancy as a predictor of treatment outcome. 
A secondary purpose of this study was to examine how individuals with insomnia 
behave when undergoing polysomnographic assessment in the home.  Research has identified 
that nocturnal recording site may impact sleep patterns (Edinger et al., 1997).  Additionally, 
PSG equipment may produce sensory intrusions for some individuals.  The potential for sleep 
to change when one is undergoing polysomnographic assessment in the home has 
implications for assessing the discrepancy between subjective and objective measures of 
insomnia and for making conclusions from objective data collected outside the lab.  Sleep 
patterns on nights when participants were undergoing polysomnographic recording in the 
home were compared to sleep patterns on nights of typical sleep, without the presence of 
recording equipment, to determine if individuals sleep differently when undergoing PSG 
assessment. 
In the following sections, a review of the relevant insomnia literature will be 
presented, focusing on studies that have examined or addressed the discrepancy between 
subjective and objective measures.  Thereafter, the following aims will be discussed: 1) to 
examine the discrepancy between subjective and objective measures of insomnia, which has 
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been established in adult insomnia populations, in a special population of older adults with 
comorbid insomnia, 2) to observe whether or not the magnitude of the discrepancy between 
subjective and objective measures is diminished post-treatment with Cognitive-Behavioral 
Therapy for Insomnia (CBT-I) compared to those receiving a placebo treatment, Stress 
Management and Wellness (SMW) therapy, 3) to examine whether scores on the 
Dysfunctional Beliefs and Attitudes about Sleep (DBAS) scale, Geriatric Depression Scale 
(GDS), Profile of Mood States (POMS) scale, and POMS tension subscale predict the size of 
the discrepancy between subjective and objective measures at pre-treatment, 4) to examine 
whether change in DBAS score from pre- to post-treatment with CBT-I will predict change 
in the magnitude of the subjective/objective discrepancy, 5) to examine if the magnitude of 
the subjective/objective discrepancy prior to treatment with CBT-I is a significant predictor 
of treatment response, 6) to examine whether change in the discrepancy from pre- to post-
treatment with CBT-I is a significant predictor of treatment response, and 7) to examine if 
participants behave differently in regard to their sleep when undergoing polysomnographic 
assessment in the home.  
Review of the Literature 
Defining Insomnia.  Prevalence rates of insomnia vary widely, with some sources 
reporting a rate of 2% and others reporting as high 42.5% (Morgan, 2000; Morin, 1993).  
One likely contributor to this wide variability is the lack of standardized quantitative criteria 
for defining insomnia (Lichstein et al., 2003).  Studies in the field of insomnia research show 
marked inconsistency in the parameters they use to inform their definition of the disorder, 
with many relying solely upon a yes or no answer from participants to the question: “Do you 
have insomnia?”  Other studies require a minimum duration or severity of subjective 
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symptoms, however these standards are inconsistent between studies and markedly few 
incorporate objective measurements into their diagnostic criteria (Lichstein, 2003).  A study 
by Lichstein and colleagues (2003) reviewed the criteria for defining insomnia in all 
psychology clinical trials for insomnia during the past two decades and found that fifty-five 
studies that specified their criteria (90.2%) relied solely on diaries and only five incorporated 
both diary and polysomnographic data into their definition.  The failure to establish 
consistent criteria for insomnia between studies may lead to unreliable reports surrounding 
the efficacy of treatments and may contribute to inaccurate epidemiological estimates of 
insomnia prevalence (Lichstein et al., 2003).  This issue is compounded by the fact that the 
three manuals for diagnosing insomnia, the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric Association 
[APA], 2000), the International Statistical Classification of Diseases and Related Health 
Problems, Tenth Revision, Second Edition (ICD-10; World Health Organization, 2004), and 
the International Classification of Sleep Disorders, 2nd Edition: Diagnostic and Coding 
Manual (ICSD2; American Academy of Sleep Medicine, 2005), each report different 
diagnostic criteria.  This, again, brings attention to the marked inconsistencies in the 
definition of insomnia and complicates the manuals’ utility for research and clinical care.  
The discrepancy between subjective and objective measures of insomnia further complicates 
this issue.  If individuals report subjective symptoms of insomnia without objective 
corroboration, the question emerges of whether they really have insomnia or if a 
psychological disorder of perception is to blame for their experience.  Without a better 
understanding of the subjective/objective discrepancy, prevalence rates and efficacy studies 
of treatments for insomnia will continue to be inconsistent and potentially inaccurate. 
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Discrepancy/Concordance Research.  Much of the literature on the discrepancy 
between subjective and objective measures of insomnia suggests that insomniacs report more 
delayed sleep onset latency, more frequent nocturnal awakenings, and lower total sleep time 
than what objective parameters show (Carskadon et al., 1976; Frankel et al., 1976).  Other 
studies, however, have shown that there is wide variability in how accurately insomniacs 
perceive their sleep (Libman, Creti, Levy, Brender, & Fichten, 1997; Edinger & Fins, 1995; 
Vanable et al., 1999).  Edinger and Fins (1995) found that while most insomniacs 
underestimated the amount of sleep they were getting, a substantial number produced 
estimates that were congruent with PSG, and nearly 20% actually overestimated total sleep 
time.  Carskadon and colleagues (1976) similarly reported that in their study, most patients 
underreported sleep time and overestimated sleep latency, but that 20% made congruent 
estimates of TST and 12% made substantial overestimates.  These findings suggest that 
subjective reports of insomnia are variable between individuals and show that many 
insomniacs are inaccurate in their estimates of sleep disturbance.   
 The presence of a subjective complaint of insomnia in individuals who exhibit 
objectively measured adequate sleep has been labeled by some as “subjective insomnia” or 
“paradoxical insomnia,” and in some cases has been suggested to be a transitional state 
between normal sleep and objectively verifiable insomnia (American Academy of Sleep 
Medicine [AASM], 2005; Dorsey & Bootzin, 1997; Salin-Pascual, Roehrs, Merlotti, Zorick, 
& Roth, 1992).  Others have debated whether insomnia should be divided into two subtypes; 
“subjective” and “objective,” to indicate the measurement method by which they meet 
criteria for insomnia and suggest it is possible that these subtypes may differ in their EEG 
sleep pathology, etiologies, or courses over time (Edinger & Krystal, 2003).  The term “sleep 
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state misperception” has also been used to classify individuals who complain of marked 
insomnia without objective corroboration and this is considered a diagnosable disorder by the 
International Classification of Sleep Disorders (ICSD) that is endorsed by an estimated 10-
25% of insomnia patients (Vanable et al., 1999).  The ICSD suggests that the disorder 
develops as a result of a marked over concern with the inability to sleep that leads to a 
vicious cycle of poor sleep (AASM, 2005).  Although there is debate as to whether the 
mismatch between subjective reports and objective measures of insomnia indicates a distinct 
subtype of insomnia, this phenomenon is frequently discussed as a generic characteristic of 
insomnia.  Some view sleep state misperception as the extreme end of a continuum of 
insomnia, with pure insomnia (both subjective and objective agreement) as the other 
extreme; however, rates of pure sleep state misperception, distinguished by a subjective 
complaint without any suggestion of insomnia by objective measures, are reported to be 
fairly low (Reynolds, Kupfer, Buysse, Coble, & Yeager, 1991; Edinger & Fins, 1995).  Most 
studies suggest that patients typically fall somewhere in between the two extreme endpoints, 
showing some objective corroboration of insomnia symptoms but reporting a 
disproportionately severe subjective complaint. 
Research on the discrepancy between subjective and objective measures of insomnia 
has suggested multiple variables that may help to explain why the discrepancy exists.  
Several studies examining personality correlates have found that overreporting of insomnia 
symptoms is associated with greater neuroticism and hypochondriasis on measures such as 
the Minnesota Multiphasic Personality Inventory (MMPI; Butcher, Dahlstrom, Graham, 
Tellegen, & Kaemmer, 1989; Corsey, Buchsbaum, & Frankel, 1975; Kales, Caldwell, 
Preston, Healey, & Kales, 1976; Tan, Kales, Kales, Soldatos, & Bixler, 1984).  These studies 
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provide evidence that personality traits may contribute to the symptom exaggeration 
exhibited by some individuals with insomnia.  Over-activation of EEG activity, or brain 
activity during sleep, has also been identified as a correlate of exaggerated subjective 
symptoms (Perlis, Giles, Mendelson, Bootzin, &Wyatt, 1997).  Studies have established that 
insomniacs are physiologically hyperaroused prior to sleep onset and/or during sleep, which 
may interfere with their ability to initiate or maintain sleep and has been shown to induce 
intrusive cognitions around the time of sleep onset (Monroe, 1967; Freedman & Sattler, 
1982; Lichstein & Rosenthal, 1980; Mitchell & White, 1977).  Other studies using newer 
methods of quantifying sleep EEG have provided evidence that diminished delta and greater 
alpha, sigma, and beta EEG spectral power in NREM sleep may be an objective physiologic 
correlate of subjective sleep complaints in individuals whose traditionally scored EEG 
profiles do not corroborate these complaints (Krystal, Edinger, Wohlgemuth, & Marsh, 
2002).  It is possible that some individuals with insomnia possess physiological 
characteristics that make them prone to overestimate their sleep disturbances; however this 
suggestion is still under investigation.  
 Mood and anxiety factors have also been found to relate to the subjective/objective 
discrepancy.  Rosa and Bonnet (2000) found that individuals complaining of insomnia 
without objective corroboration showed higher anxiety and more negative mood compared 
with those who did not report insomnia complaints.  The authors suggest that their symptoms 
may be the result of a state of tension and anxious hyperarousal rather than sleep debt and 
imply that treatment for insomnia should be focused on reducing this anxiety and 
hyperarousal rather than on objective sleep.  In a study by Edinger and colleagues (2000), 
individuals complaining of insomnia without objective corroboration reported more 
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depressed mood, anxiety, and dysfunctional sleep-related cognitions as compared to those 
whose objective measures agreed with their subjective complaints.   
 Sleep-related cognitions have been the focus of related studies, whose findings have 
established that insomniacs report more dysfunctional sleep-related cognitions than non-
complaining individuals (Morin, 1993; Edinger et al., 2000).  Many insomniacs have 
catastrophic expectations about the impact of poor sleep, which may play an important role 
in the exaggeration of self-reports of sleep disturbance and ultimately in the maintenance of 
the disorder (Perlis et al., 1997).  One example of a dysfunctional belief about sleep is an 
individual’s belief that he or she must sleep through the night without any awakenings in 
order to feel sufficiently refreshed the next day.  This thought is problematic because 
nocturnal awakenings are a normal part of sleep and unrealistic expectations about this aspect 
of normal sleep may promote worry and rumination that could in fact promote more time 
spent awake at night (Kaplan, Talbot, & Harvey, 2009).  Other dysfunctional beliefs may 
take the form of more general concerns about the long-term negative consequences of 
chronic insomnia.  Researchers have found that these beliefs predict a chronic pattern of poor 
sleep, even when arousal, depression, anxiety, and beliefs about short-term consequences of 
insomnia are controlled for (Jansson & Linton, 2007).  Other studies exploring the 
psychological aspects of insomnia have suggested that maladaptive beliefs and cognitions 
about sleep may induce sleep-related arousal, which has been identified to be a potential 
contributing factor in the development and maintenance of insomnia (Morin, 1993).   
 Research has also demonstrated a connection between sleep-related cognitions and 
treatment outcome after cognitive-behavioral therapy for insomnia (CBT-I), which has been 
identified as the most effective treatment for chronic insomnia (Espie, 1999; Espie, Inglis, & 
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Harvey, 2001).  It has been hypothesized that CBT-I reduces sleep-related arousal by 
changing maladaptive beliefs and attitudes that are believed to maintain the arousal (Morin, 
1993).  The results of a study by Espie, Inglis, and Harvey (2001) demonstrated that higher 
scores on the Dysfunctional Beliefs and Attitudes about Sleep scale, suggesting stronger 
endorsement of beliefs about the negative long-term consequences of insomnia, were 
associated with positive treatment response.  This counterintuitive finding suggests that 
dysfunctional beliefs play a potentially significant role in determining treatment outcome and 
provides evidence that CBT intervention can effectively change these beliefs.  A study by 
Edinger and colleagues (2008) indicated that patients with a high degree of unhelpful sleep 
cognitions were more likely to benefit from CBT-I than patients who had lower levels of 
unhelpful sleep related thoughts.  The authors concluded that pre-therapy sleep cognitions 
could be useful in identifying which patients would benefit most from CBT-I treatment, 
which has a cognitive treatment component specifically included to combat faulty sleep-
related beliefs.  Misperception of sleep such that an individual reports significantly more 
disturbed sleep than what objective measures show could also be considered a dysfunctional 
belief or maladaptive pattern of thinking.  For this reason it could be hypothesized that the 
subjective/objective discrepancy will be a correlate of score on the Dysfunctional Beliefs and 
Attitudes about Sleep (DBAS) Scale and may therefore be a predictor of treatment response 
to CBT, as well. 
Polysomnography in the Home versus in the Lab.  Polysomnography (PSG), 
which has been established as the primary objective measure for most sleep disorders, 
involves connecting electrodes with leads to various parts of the scalp, face, torso, and limbs 
to record eye movements, oxygen intake, snoring, facial movement, limb movement, lung 
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expansion, and EEG activity associated with specific stages of sleep (Bae & Avidan, 2008).  
PSG has traditionally been performed in sleep laboratories under the direction of sleep 
technologists who monitor the individual during nocturnal recording. 
Considering the high laboratory costs and the potential for the laboratory sleep setting 
to alter an individual’s normal sleep patterns and satisfaction with their sleep, ambulatory 
PSG conducted in the home of the sleeper has been proposed as a more cost effective and 
valid measure of everyday sleep patterns.  For normal sleepers the familiar cues of the home 
sleeping environment provide a sense of stability that facilitates the sleep process (Edinger et 
al., 2001).  Sleeping in the lab, therefore, without these predictable cues may adversely affect 
the sleep of these individuals unless they are given numerous nights to adjust to the setting.   
Alternatively, for insomniacs the cues associated with the home environment may serve as 
conditioned stimuli that produce arousal at bedtime and ultimately perpetuate sleep 
disturbances.  Polysomnographic recordings in the lab may underestimate insomniacs’ sleep 
problems at home because the cues that facilitate arousal and problematic sleep are absent, 
leading them to experience fewer sleep disturbances and report higher satisfaction with their 
sleep (Edinger et al., 2001).   
It is also reasonable to suggest that the absence of sleep technologists during home 
assessment may promote differences in sleep behavior  relative to the laboratory sleep.  
Despite instructions given by the sleep technologist to not change their sleep habits on the 
night of PSG measurement, individuals undergoing assessment in their home setting may 
potentially discontinue recording upon waking due to the discomfort of the PSG equipment, 
therefore truncating their night’s sleep.  Research in insomnia has recognized how the sleep 
setting may affect individuals’ sleep but there has been little specific focus on how sleep 
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behavior may change when an individual is undergoing PSG assessment at home.  Although 
individuals are advised to maintain the standards adhered to in the lab, the recording 
conditions cannot always be standardized or controlled.   
Statement of the Problem 
 Rationale.  Research has established that many insomniacs report subjective 
symptoms of insomnia that are greater in severity than what is demonstrated by objective 
measures, namely polysomnography; however few studies have focused this research in the 
older adult population, for whom insomnia is disproportionately prevalent.  Also, few studies 
have examined the discrepancy in depth by questioning how it responds to treatment with 
cognitive-behavioral therapy or how dysfunctional beliefs about sleep or depression and 
anxiety scores may predict the magnitude of the discrepancy.  This study will contribute to 
the literature by studying the subjective/objective discrepancy in a unique sample of older 
adults with comorbid insomnia and by taking one step beyond much of the existing 
discrepancy literature to assess its connection with dysfunctional attitudes about sleep and 
response to the cognitive-behavioral treatment designed to address them.  Because few 
treatment studies have examined sleep using both subjective and objective measures and 
considered the potential for misperception, this study makes a unique contribution to the field 
of insomnia research.  Additionally, since this study includes individuals who underwent 
polysomnographic assessment at home, rather than in the lab, we will be able to examine 
whether individuals discontinued recording early to avoid prolonging the discomfort and 
inconvenience of being tethered to electrodes and other monitoring devices. 
Study Aims.  The aims of the current study were: 1) to examine the discrepancy 
between subjective and objective measures of insomnia, which has been previously 
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established in adult insomnia populations, in a special population of older adults with 
comorbid insomnia, 2) to observe whether or not the severity of the discrepancy between 
subjective and objective measures is diminished post-treatment with Cognitive Behavioral 
Therapy for Insomnia (CBT-I) compared to those receiving a placebo treatment, Stress 
Management and Wellness (SMW) therapy, 3) to examine whether scores on the DBAS 
scale, Geriatric Depression Scale (GDS), Profile of Mood States (POMS) scale, and POMS 
tension subscale predict the size of the discrepancy between subjective and objective 
measures at pre-treatment, 4) to examine whether change in DBAS score from pre- to post-
treatment with CBT-I will predict change in the magnitude of the subjective/objective 
discrepancy, 5) to examine if the magnitude of the subjective/objective discrepancy prior to 
treatment with CBT-I is a significant predictor of treatment response, 6) to examine whether 
change in the discrepancy from pre- to post-treatment with CBT-I is a significant predictor of 
treatment response, and 7) to examine if participants behave differently in regard to their 
sleep when undergoing polysomnographic assessment in the home. 
Hypotheses.  Based on the aforementioned literature and in consideration of the 
study aims, the following hypotheses were proposed:  
1) As has been demonstrated in adult insomnia populations, there will be a significant 
discrepancy between subjective (diary) and objective (PSG) measures of insomnia in the 
combined sample of older adults with comorbid insomnia at baseline. 
2) The magnitude of the discrepancy between subjective and objective measures will 
be significantly diminished post-treatment with Cognitive Behavioral Therapy for Insomnia 
(CBT-I) but not post treatment with Stress Management and Wellness (SMW) therapy, 
suggesting that CBT-I improves insomniacs’ ability to accurately report sleep symptoms. 
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3) DBAS, GDS, and POMS scores will significantly predict the magnitude of 
discrepancy between subjective and objective measures at pre-treatment, demonstrating that 
dysfunctional beliefs about sleep, depression, and tension (i.e. anxiety) are correlates of the 
subjective/objective discrepancy. 
4) Change in DBAS score from pre- to post-treatment with CBT-I will predict change 
in the magnitude of the subjective/objective discrepancy, demonstrating a relationship 
between dysfunctional beliefs about sleep and the subjective/objective discrepancy.  
5) The size of the subjective/objective discrepancy prior to treatment with CBT-I will 
be a significant predictor of treatment response.  
6) Change in the magnitude of the subjective/objective discrepancy from pre- to post-
treatment will significantly predict change in sleep efficiency, indicating that improvement in 
the accuracy of one’s perceptions of sleep is a predictor of treatment response.  
7) Sleep measures will indicate that participants will sleep differently on the two PSG 
nights compared to the full two weeks of sleep diary data due to sensory intrusions and a 
disruption of their sleep routine.  Specifically, they will spend less time in bed overall and 
demonstrate longer sleep onset latency, shorter total sleep time, and more nocturnal 
awakening time.   
Method 
Participants 
The current study is a secondary analysis of data collected from a previously 
conducted randomized clinical trial funded by an R01 grant from the National Institutes of 
Health (NIH).  The original study compared Cognitive-Behavioral Therapy for Insomnia 
(CBT-I) to a Stress Management and Wellness (SMW) therapy placebo condition for older 
 17 
 
adults with comorbid insomnia (Rybarczyk et al. 2005).  The study protocol was approved by 
the Rush University Medical Center Institutional Review Board (IRB) and participants 
involved gave written informed consent prior to enrollment.  Inclusion criteria for 
participation in the study consisted of: a) 55 years of age or older, b) have had at least three 
episodes of insomnia per week for at least 6 months, c) suffer from daytime consequences of 
insomnia such as fatigue or trouble concentrating, and c) suffer from OA, CAD, or COPD.  
Exclusion criteria included: a) diagnoses of restless leg syndrome, sleep apnea, or other sleep 
disorders, b) consumption of more than a standard dose of sleep medication, c) medical 
conditions that are highly to likely to cause sleep disturbances such as diabetes or 
Parkinson’s disease, and d) self report of major psychiatric disorder or history of psychiatric 
hospitalization. 
Participants were recruited between January 2001 and October 2003 via flyers left in 
medical offices and senior centers and letters sent in the mail to addresses provided by 
doctor’s offices or disease related support organizations.  Those who expressed interest in 
participating in the study were first screened by telephone to determine eligibility for 
participation using the above listed inclusion and exclusion criteria.  
Participants who were identified through telephone screening as eligible for 
participation were subsequently required to complete one night of polysomnographic 
assessment in the home to screen for sleep disorders such as sleep apnea or periodic leg 
movement disorder (PLMD).  This assessment also allowed participants one night of 
acclimation to the PSG technology to promote some level of desensitization to the 
equipment.  Due to an increased prevalence of sleep apnea and PLMD in older adults, 
exclusion thresholds were set so that individuals with mild indications of these sleep 
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disorders could be included in the study as long as neither could be considered the primary 
cause of insomnia (Ancoli-Isreal, Kripke, & Klauber, 1991a, Ancoli-Isreal, Kripke, & 
Klauber, 1991b).  To screen for more severe cases of sleep apnea and PLMD, a board-
certified sleep specialist reviewed the polysomnographic results for indications of sleep 
apnea and PLMD and participants who endorsed moderate to severe cases of either of these 
sleep disorders were subsequently excluded from the study.  The exclusion cutoff for the 
apnea/hypopnea index, which identifies the severity of sleep apnea based on the total number 
of breathing cessations (apneas) and partial obstructions (hypopneas) occurring per hour of 
sleep) was > 15.  For the periodic leg movement index used in PLMD, the exclusion cutoff 
was > 30.  This index identifies the severity of PLMD based on the number of period limb 
movements per hour of sleep.  Potential participants were also given the Mini-Mental State 
Examination (MMSE) during the initial home visit, on which they were required to score at 
least a 24 (Folstein, Folstein, & McHugh, 1975).  This was administered to screen out high 
levels of psychiatric illness that could confound the treatment effect.  Four hundred sixty-two 
individuals contacted study staff and met the inclusion criteria for age, medical diagnosis, 
and level of insomnia.  Of these, 149 were excluded due to diagnosis of a primary sleep 
disorder other than insomnia and 135 were excluded due to a diagnosis of a comorbid 
medical or psychiatric condition that may complicate insomnia treatment. 
Ninety-two participants completed the original study.  These participants were 
randomly assigned to either a CBT-I or a Stress Management and Wellness (SMW) treatment 
group using a block randomization procedure.  No differences in age, gender, education, 
race, distribution of the targeted chronic illnesses, number of other chronic illnesses, or sleep 
medication usage were found between the groups (all ps ≥ .10).  The intervention programs 
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were matched in as many characteristics as possible, including location (an academic medical 
center in downtown Chicago), experience level and skill of instructors, amount of group 
discussion and question-and-answer time, course materials, and refreshments.  The 
interventions were conducted in eight 2-hour classes held on a weekly basis and were 
administered in 22 separate groups.  The average group size was five people.  Transportation 
was paid for by the study for the purpose of encouraging participation of individuals at all 
income levels.   
 Two clinical psychologists with extensive experience in conducting cognitive-
behavioral therapy for Insomnia (CBT-I) led the CBT-I sessions.  Each session included a 
didactic presentation, a question-and-answer period, and a review of each individual’s sleep 
log, followed by a group discussion to address any problems encountered during 
implementation of the techniques at home.  With the exception of an added relaxation 
training component, the CBT-I treatment intervention followed Morin’s (1993) insomnia 
treatment protocol, which includes individual modules for stimulus control, sleep restriction, 
cognitive restructuring, and sleep hygiene.  
 The Stress Management and Wellness (SMW) treatment adapted from Rybarczyk and 
colleagues (2001), consisted of didactic presentations and corresponding skill training 
lessons covering the following six topics: 1) the mind/body relationship; 2) modifying self-
talk for the reduction of stress and anxiety; 3) effective communication and assertiveness; 4) 
problem-solving and goal setting; 5) nutrition; and 6) exercise for individuals with chronic 
conditions.  A physician with extensive training and speaking experience regarding 
mind/body health covered topics 1 and 2 over four separate class sessions.  Topics 3 and 4 
were covered by a clinical psychologist and topics 5 and 6 were covered by an expert 
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nutritionist and exercise physiologist.  Of the 44 SMW participants who completed treatment, 
26 continued to have sleep problems and were subsequently offered the opportunity to 
participate in the CBT treatment after the posttreatment assessment.   
 Measures of sleep were collected using sleep diaries completed by participants over a 
period of two weeks at pre-treatment (within a one month period prior to treatment) and post-
treatment (during a 1-month period after treatment ended).  Data was also collected at one-
year follow-up; however, this data was not included in the secondary analysis.  On two nights 
during each of these two-week periods, participants also underwent two nights of home 
polysomnographic (PSG) assessment.  Collecting both diary and PSG measures of sleep on 
the same night allowed for direct comparison of subjective and objective data.   
The present analysis is based on data from a subset of the participants from the 
original study.  Participants from the original study were excluded based on three criteria: 1) 
was a crossover from SMW to CBT, 2) did not meet criteria for insomnia during the two-
week period at baseline (specifically, sleep onset latency < 30 minutes, total sleep time > 390 
minutes, or wake time after sleep onset < 60 minutes), and 3) significant missing data (diary 
or PSG) that would compromise statistical analysis.  Participants excluded for missing data 
were missing two or more nights of data as collected by diary and/or polysomnography. 
Seventeen participants were excluded for missing two or more nights of data as collected by 
diary and/or polysomnography.  For the 11 participants who were missing only a single night 
of either diary or PSG data, the decision was made to impute data from the previous or 
subsequent night of sleep to the missing cell rather than to exclude the participant from the 
analysis.   
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Of the participants from the original study, 62 were identified as meeting criteria for 
insomnia and having complete data for the variables of interest.  Two of these participants 
were excluded due to extreme values that were highly likely to be erroneous.   Of the 
remaining 60 participants who were included in this secondary analysis, 18 were male and 42 
were female. The mean age of the participants was 69.17 (SD=8.9) and 44 were Caucasian, 
13 were African American, 2 were Hispanic, and 1 was Asian. The average education level 
was 15.02 years (SD=3.2).  There were no significant differences between the two treatment 
conditions in baseline demographic data, number of chronic illnesses, or baseline sleep 
efficiency (all ps > .13; see Table 1).  
 
Table 1.  
Demographics and Other Baseline Characteristics by Treatment Group 
 
 CBT-I (n = 33) SMW (n = 27) 
21 female 21 female Gender 
12 male 6 male 
Mean Age (SD) 70.73 (9.2) 67.26 (8.2) 
Mean years of Education 
(SD) 15.51 (4.0) 14.43 (1.7) 
73% Caucasian (24) 74% Caucasian (20) 
21% African-American (7) 22% African-American (6) 
3 % Hispanic (1) 4% Hispanic (1) 
Race 
3% Asian (1) 0%  Asian (0) 
 6 COPD 4 COPD 
17 CA 10 CA Chronic Illnesses 
14 OA 17 OA 
Mean Number of Chronic 
Illnesses (SD) 1.12 (.33) 1.15 (.36) 
Mean Baseline Sleep 
Efficiency (%;SD) 69.69 (13.34) 67.72 (13.45) 
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Secondary analysis of this data set qualified for exemption by Virginia 
Commonwealth University’s Institutional Review Board under the study title, “The 
discrepancy between subjective and objective measures of insomnia in older adults with 
comorbid insomnia” (IRB# HM13113).   
Measures 
Sleep log.  Sleep logs, paper-and-pencil records of nightly sleep patterns, were 
completed by participants each morning for two weeks at pretreatment (during the month 
prior to treatment), two weeks following posttreatment (during the month after treatment 
ended), and weekly during the CBT class.  Participants were asked to record sleep latency, 
total sleep time, awakenings (quantity and duration), time in bed, length and frequency of 
naps, and any medication used for sleep (see Appendix 1 for measure). 
Dysfunctional Beliefs and Attitudes about Sleep scale (DBAS).  The DBAS scale 
(Morin et al., 1993) is a 30-item scale designed to measure various beliefs, attitudes, 
expectations, and attributions about sleep and insomnia.  These cognitions involve five 
conceptually-derived scales that can be used on their own or combined for a global score: 
misattributions or amplification of the consequences of insomnia, diminished perception of 
control and predictability of sleep, unrealistic sleep expectations, misconceptions about the 
causes of insomnia, and faulty beliefs about sleep promoting practices.  Items include a 100-
mm visual analog scale, with “strongly disagree” and “strongly agree” descriptors at each 
end of the scale. The DBAS has demonstrated adequate reliability and validity (Morin et al, 
1993).    
 Geriatric Depression Scale (GDS).  The GDS (Brink et al., 1982) was developed 
specifically for use with older adults and is comprised of 30 items in a simple “yes/no” 
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answer format.  None of the items reflect the somatic and vegetative aspects of depression, 
which reduces the possible confounds of depressive and age-related medical illness 
symptoms.   
Profile of Mood States scale (POMS).  The POMS (McNair, Lorr, & Droppleman, 
1971) is a 65-item self-report measure of affective states for the past week. Patients are 
asked to rate their mood on a 5-point Likert scale ranging from not at all to extremely. The 
instrument consists of six subscales for the dimensions of vigor, tension, depression, anger, 
fatigue, and confusion. It has good test–retest reliability, predictive construct validity, and 
concurrent validity (McNair et al., 1971). The POMS total mood disturbance score, which 
includes all but the Vigor subscale, will be used as an overall indicator of distress and the 
Tension subscale will be used as a measure of anxiety. 
Procedure 
 Polysomnographic Procedures.  All PSGs were conducted in the subjects’ homes.  
Each study included standard placement of electrodes for continuous monitoring of the 
central and occipital electroencephalograms (EEG), electrooculogram (EOG), submental 
electromyogram (EMG) and one chest lead for cardiac rhythm (EKG), nasal airflow 
measured with a pressure transducer, oral respiration measured with a thermistor, and 
bilateral leg (anterior tibialis) electromyograms.  Sleep recordings were made using the 
Compumedics P-Series Sleep Monitoring System (Compumedics, Australia).  All electrode 
impedances were less than 10,000 ohms.  Sleep studies were conducted during each 
subject’s typical sleep period based on self-report. 
Each PSG recording was archived to optical disk and scored manually in 30-second 
epochs according to standard criteria (Rechtshaffen & Kales, 1968).  Records were coded 
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so that scorers remained blind to the experimental conditions. The inter-rater reliability was 
maintained at 90% or higher.  Apnea episodes were defined by the standard criteria of 10 
seconds or longer of no nasal or oral airflow.  Hypopnea episodes were defined as a period 
greater than 10 seconds with airflow 50% or less of baseline amplitude and accompanied 
by oxygen desaturation of 3% or greater.   
Sleep Parameters.  Four standard parameters that measure different aspects of 
impaired sleep were collected using the two measurement types (sleep log, 
polysomnography) and compared at four time points (two at pre-treatment and two at post-
treatment).  These parameters included: 1) Sleep efficiency (SE), 2) Sleep onset latency 
(SOL), 3) Total sleep time (TST), and 4) Wake time after sleep onset (WASO).  Sleep 
efficiency (SE), defined as the ratio of time spent asleep to time spent in bed, is a reliable 
composite index of sleep disturbance severity and measure of sleep improvement (Gagné & 
Morin, 2001).  It is obtained by dividing the total amount of time spent asleep by the total 
amount of time spent in bed per night and multiplying the result by 100.  A cut off of 85% is 
traditionally used to distinguish good sleepers from bad sleepers.  Sleep onset latency (SOL) 
refers to the time between the point when an individual tries to sleep and the point when 
sleep is actually initiated and encephalographic patterns of sleep first develop.  Total sleep 
time (TST) is defined as the amount of time spent asleep.  Wake time after sleep onset 
(WASO) is defined as the amount of time spent awake after sleep is initiated.   
Data Analysis.  Statistical analyses were performed using PASW Statistics 18 
software (formerly SPSS for Windows).  Paired t-tests between sleep diary estimates and 
polysomnographic measures of sleep were used to determine the presence of a significant 
discrepancy between subjective and objective measures of sleep efficiency, sleep onset 
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latency, total sleep time, and wake time after sleep onset.  Multiple analysis of variance 
(MANOVA) was used to analyze differences in the magnitude of this discrepancy between 
treatment groups at pre- versus post-treatment.  Based on the aforementioned hypotheses, 
regression analyses were also conducted to analyze predictors of the magnitude of or changes 
in the discrepancy and to examine the relationship between the discrepancy and measures of 
treatment response.  Finally, paired t-tests were used to compare sleep behaviors on PSG 
nights with sleep behaviors on nights with no polysomnographic assessment.  In order to 
complete these analyses, two nights of data for each sleep parameter (measured by either 
sleep diary or polysomnography) were averaged together at each time point to create a pre- 
and post-treatment mean.  By calculating the difference between sleep diary and 
polysomnography means, variables were created to capture the magnitude of the discrepancy 
at pre-treatment and post-treatment as well as the difference between these.  Whereas this 
study sought to examine the pattern of underestimating sleep (reporting greater deficits than 
objective measures corroborate), a proportion of the participants showed a positive rather 
than negative bias (reporting fewer deficits than were observed using objective measures).  
For the purposes of this study and to avoid analyses using negative numbers, only “negative 
discrepancy” was examined (i.e., diary data that reported a lower sleep efficiency than what 
was recorded by PSG).  Average discrepancy at pre-treatment and post-treatment were 
calculated by subtracting the diary estimate from the PSG estimate and any negative numbers 
(indicating positive rather than negative bias) were substituted with “0.”  Conversions of 
positive bias were only used for regression analyses looking at predictors of discrepancy in 
sleep efficiency.  It should be noted that no conversions were done for the MANOVAs used 
to test the first two study hypotheses.  Among the 60 study participants, there were only 19 
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instances of significant positive discrepancy (> 5% difference).  That was in contrast to 56 
instances of significant negative discrepancy (<5%) and 45 instances of neutral estimation 
(within ±5%).   
Results 
Discrepancy between subjective and objective measures 
 To test the first hypothesis, that there would be a significant discrepancy between 
subjective and objective measures of insomnia, paired t-tests were used.  Pairs were created 
between sleep diary and polysomnography variables for each parameter (SE, SOL, TST, 
WASO) at baseline.  Prior to the analysis, statistical assumptions of normality and 
homogeneity of variance were checked.  Normality was assessed by examining skewness and 
kurtosis statistics.  Due to positive skew observed for sleep onset latency and wake time after 
sleep onset variables, both sleep diary and polysomnography variables for these parameters 
were transformed.  Wake time after sleep onset variables were transformed using square root 
transformations and sleep onset latency variables were transformed using log transformation 
due to more severe skew.  Levene's test was used to assess homogeneity of variance and 
nonsignificant results for this preliminary analysis indicated no violation of this assumption.    
 Results of the paired t-tests show that significant differences were observed at 
baseline between sleep diary estimates and polysomnography measures for sleep efficiency, 
t(59) = -5.33, p < .001; sleep onset latency, t(59) = 7.17, p < .001; and total sleep time, t(59) 
= -5.06, p < .001; with sleep diaries indicating more severe sleep disturbance than 
polysomnography.  These results provide support for the first hypothesis; however, results of 
the paired t-test for wake time after sleep onset were not significant (p = .29).  This indicates 
the absence of a significant discrepancy between measures of wake time after sleep onset at 
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baseline and fails to provide support for the first hypothesis.  See Table 2 for baseline means 
and standard deviations for all participants.  Norms from a published study of 20 healthy 
older adults using home polysomnography are also included (McCall, Erwin, Edinger, 
Krystal, and Marsh, 1992).   
 
Table 2. 
Sleep Diary and Polysomnography Norms and Means for Each Parameter at Baseline 
  LOG PSG NORM 
  Mean SD Mean SD Mean 
Sleep Efficiency (%)  68.19 18.63 78.07 10.14 84.6 
Sleep Onset Latency 
(minutes) 44.62 42.7 14.22 14.49 12.9 
Total Sleep Time (minutes) 315.85 97.47 371.52 68.84 372.0 
Wake Time after  
Sleep Onset (minutes) 70.45 64.3 58.91 38.37 52.0 
 
 As illustrated in Figure 1, below, the range of discrepancy between subjective and 
objective measures of sleep efficiency is reduced for those who have high sleep efficiency.  
With greater time spent awake between bedtime and wake time (i.e. longer sleep onset 
latency and more awakenings after sleep onset), there is more opportunity for misperception 
to occur, resulting in greater discrepancy.  
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Figure 1. Relationship between Subjective/Objective Discrepancy and Sleep Efficiency 
 
 
Change in discrepancy following treatment 
To test the second hypothesis, that this discrepancy would significantly decrease 
following treatment with CBT-I but not with SMW, multivariate analyses of variance 
(MANOVAs) were used.  One MANOVA was conducted for each parameter (sleep 
efficiency, sleep onset latency, total sleep time, and wake time after sleep onset), with within-
subjects factors consisting of the parameter measured during two nights at each time point 
assessed by either sleep diary or polysomnography and class group entered as the between-
subjects factor.    
Prior to the primary analysis, data were checked for statistical assumptions, including 
normality, linearity, homogeneity of variance, and homogeneity of covariance matrices.  
Univariate and multivariate outliers were identified using mahalanobis distance and by 
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examining boxplots.  Although several were identified, these were judged to be real values of 
the population and were thus included in the analysis.  Variables were also checked for 
normality using skewness and kurtosis statistics.  Values greater than 1 were observed for 
sleep efficiency, sleep latency, and wake time after sleep onset variables, indicating that the 
assumption of normality was violated.  To address this, affected variables were subsequently 
transformed.  Square root transformations were applied to all sleep efficiency and wake time 
after sleep onset variables.  Due to more severe skew, sleep onset latency variables were 
transformed using log transformations.  Following these adjustments, skewness and kurtosis 
were reduced and normality for these variables was significantly improved.  Scatterplots of 
the dependent variables were eyeballed for linearity and due to the linear relationship 
observed between the data points, this assumption was determined to be met. 
Multicollinearity was examined prior to analysis by running bivariate correlations 
between the variables.  Correlation coefficients were all under .65, suggesting that there were 
no significant problems with multicollinearity.  After running the MANOVAs for each sleep 
parameter, the assumption of homogeneity of variance-covariance matrices was checked 
using Box’s M Test of Equality of Covariance Matrices.  This test was nonsignificant for 
sleep efficiency, indicating that the assumption was met, but was significant for sleep onset 
latency, total sleep time, and wake time after sleep onset.  Because sample sizes between 
groups are nearly equal, this poses little threat to the assumption; however, Pillai's Trace will 
be the test statistic reported for all MANOVAs because of its known robustness when sample 
sizes are equal (Field, 2009).  To test for equality of error variances, Levene’s test was used.  
Significant results of this test for sleep efficiency measured by log at two time points 
suggested possible violation of the assumption; however, because Box's M Test was 
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nonsignificant, this is not a concern.  Levene's test was also significant for one sleep latency 
and one wake time after sleep onset variable; however, because the sample sizes are nearly 
equivalent between groups, there is little concern for violation of this assumption.   
 To more meaningfully interpret patterns observed in the participants’ sleep, original 
variables (before transformations were conducted to make data acceptable for use with 
parametric tests), are provided in Tables 3.1 - 3.4.  As previously mentioned, two nights of 
data were averaged together to create a single mean score for each measurement type at each 
time point.  MANOVA results showed significant differences between measures of sleep 
efficiency by group and across time, as evidenced by a significant measure*time*group 
effect, Pillai's Trace = .07, F(1,58) = 4.37, p < .05, multivariate η2 = .07.  Both groups 
underestimated sleep efficiency at baseline.  The CBT group underestimated sleep efficiency 
by an average of 9% and the SMW by an average of nearly 10.9%.  After treatment, 
discrepancy in the CBT group was 3%, whereas discrepancy in the SMW group was 7.6%.  
The CBT group diminished their discrepancy by an average of 6%, while discrepancy in the 
SMW group was reduced by an average of only 3% (see Figure 2).  Interestingly, positive 
discrepancy was observed for the CBT group as a whole at post-treatment, indicating that 
participants overestimated rather than underestimated sleep efficiency; however, follow-up 
analysis revealed that this post-treatment discrepancy was nonsignificant.  A post-hoc paired 
t-test was conducted for the CBT group following the MANOVA to compare measures of 
sleep efficiency at post-treatment and results of this analysis show that subjective and 
objective measures were not significantly different, t(32) = 1.869, p =.071. 
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Table 3.1.  
Sleep Efficiency Means at Pre- and Post-Treatment by Measurement Method 
 
SLEEP EFFICIENCY    
Pre-Treatment    
CBT Group N Mean SD 
14-day Diary 33 .6969 .1335 
2-day Diary 33 .7036 .1469 
2-day PSG 33 .7939 .0956 
    
Pre-Treatment    
SMW Group N Mean SD 
14-day Diary 27 .6772 .1345 
2-day Diary 27 .6553 .2255 
2-day PSG 27 .7645 .1076 
    
Post-Treatment    
CBT Group N Mean SD 
14-day Diary 33 .8547 .0778 
2-day Diarya 33 .8304 .1021 
2-day PSG 33 .8007 .1117 
    
Post-Treatment    
SMW Group N Mean SD 
14-day Diary 27 .7388 .1409 
2-day Diary 27 .6981 .1729 
2-day PSG 27 .7739 .1046 
  
a Paired t-test comparing 2-day sleep diary to 2-day PSG; not significant 
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Figure 2.  Discrepancy between Subjective and Objective Measures of Sleep Efficiency by
      Group at Pre- and Post-Treatment 
 
 
 MANOVA results showed significant differences between measures of sleep onset 
latency by group and across time, as evidenced by a significant measure*time*group effect, 
Pillai's Trace = .14, F(1,58) = 9.15, p < .01, multivariate η2 = .14.  At baseline, the CBT 
group overestimated sleep onset latency by an average of around 35 minutes, while the SMW 
group overestimated by an average of 24.8 minutes.  After treatment, the CBT group 
significantly closed the gap between subjective and objective measures of sleep onset 
latency, reducing their discrepancy to an average of just under 3 minutes; an improvement of 
32 minutes.  The SMW group, however, only reduced discrepancy to an average of 16 
minutes; an improvement of just 8.7 minutes (Figure 3).  A post-hoc paired t-test was 
conducted for the CBT group following the MANOVA to compare measures of sleep onset 
latency at post-treatment.  Results of this analysis show that subjective and objective 
measures were not significantly different, t(32) = 1.308, p =.20. 
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Table 3.2.   
Sleep Onset Latency Means at Pre- and Post-Treatment by Measurement Method 
 
b Paired t-test comparing 2-day sleep diary to 2-day PSG; not significant 
  
 
SLEEP ONSET LATENCY    
Pre-Treatment    
CBT Group N Mean SD 
14-day Diary 33 51.52 57.37 
2-day Diary 33 50.00 45.96 
2-day PSG 33 15.05 17.53 
    
Pre-Treatment    
SMW Group N Mean SD 
14-day Diary 27 38.30 27.70 
2-day Diary 27 38.04 38.15 
2-day PSG 27 13.20 9.81 
    
Post-Treatment    
CBT Group N Mean SD 
14-day Diary 33 19.76 16.85 
2-day Diaryb 33 16.89 12.98 
2-day PSG 33 14.00 13.42 
    
Post-Treatment    
SMW Group N Mean SD 
14-day Diary 27 33.30 30.51 
2-day Diary 27 30.70 23.87 
2-day PSG 27 14.57 12.24 
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Figure 3. Discrepancy between Subjective and Objective Measures of Sleep Onset Latency 
     by Group at Pre- and Post-Treatment 
 
 
 MANOVA results showed marginally significant differences between measures of 
total sleep time by group and across time, as evidenced by a nearly significant 
measure*time*group effect, Pillai's Trace = .06, F(1,58) = 3.92, p = .052, multivariate η2 = 
.07.  Both groups underestimated total sleep time at baseline.  The CBT group 
underestimated total sleep time by an average of around 47 minutes, while the SMW group 
underestimated by an average of 65 minutes.  After treatment, discrepancy between 
subjective and objective measures of total sleep time was diminished to an average of 7 in the 
CBT group; an improvement of 40 minutes.  A post-hoc paired t-test was conducted for the 
CBT group following the MANOVA to compare measures of total sleep time at post-
treatment.  Results of this analysis show that subjective and objective measures were not 
significantly different, t(32) = -7.13, p =.48.  For the SMW group, discrepancy actually 
increased to nearly 73 minutes; an increase of 8 minutes when compared to the pre-treatment 
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discrepancy (Figure 4).  The marginal nature of the measure*time*group effect may be a 
result of the lack of significant change in discrepancy observed from pre- to post-treatment in 
the SMW group.  
 
Table 3.3.  
Total Sleep Time Means at Pre- and Post-Treatment by Measurement Method 
 
cPaired t-test comparing 2-day sleep diary to 2-day PSG; not significant 
  
   
 
TOTAL SLEEP TIME    
Pre-Treatment    
CBT Group N Mean SD 
14-day Diary 33 320.94 59.02 
2-day Diary 33 318.18 75.68 
2-day PSG 33 365.83 72.08 
    
Pre-Treatment    
SMW Group N Mean SD 
14-day Diary 27 315.70 75.77 
2-day Diary 27 313.02 120.38 
2-day PSG 27 378.46 65.31 
    
Post-Treatment    
CBT Group N Mean SD 
14-day Diary 33 358.88 55.12 
2-day Diaryc 33 342.08 56.68 
2-day PSG 33 349.19 59.65 
    
Post-Treatment    
SMW Group N Mean SD 
14-day Diary 27 354.74 66.16 
2-day Diary 27 327.02 71.73 
2-day PSG 27 399.78 62.26 
 36 
 
0
10
20
30
40
50
60
70
80
Pre-Treatment Post-Treatment
D
isc
re
pa
nc
y 
(M
in
ut
es
)
CBT
SMW
 
Figure 4. Discrepancy between Subjective and Objective Measures of Total Sleep Time       
     by Group at Pre- and Post-Treatment 
 
  
 MANOVA results showed marginally significant differences between measures of 
wake time after sleep onset by group and across time, as evidenced by a nearly significant 
measure*time*group effect, Pillai's Trace = .06 , F(1,58) = 3.89, p = .054, multivariate η2 = 
.06.  Both groups overestimated wake time at baseline; although not by a statistically 
significant amount.  The CBT group overestimated wake time after sleep onset by an average 
of only 6 minutes, while the SMW group overestimated by an average of 18 minutes.  After 
treatment, discrepancy in the CBT group actually increased from an average of only 6 to an 
average of 24 minutes; however, it was noted that they moved from overestimating to 
underestimating.  Discrepancy in the SMW group diminished from 18 minutes to just over 14 
minutes; an improvement of nearly 4 minutes.  A post-hoc paired t-test was conducted for the 
CBT group following the MANOVA to compare measures of wake time after sleep onset at 
post-treatment.  Results of this analysis show that subjective and objective measures were 
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significantly different, t(32) = 3.93, p < .001.  The marginal nature of the 
measure*time*group effect may be a result of the switch from overestimating at pre-
treatment to significantly underestimating at post-treatment observed for the CBT group.   
 
 
Table 3.4.  
Wake Time after Sleep Onset Means at Pre- and Post-Treatment by Measurement Method 
 
dPaired t-test comparing 2-day sleep diary to 2-day PSG; p <.001 
 
  
   
WASO    
Pre-Treatment    
CBT Group N Mean SD 
14-day Diary 33 51.82 42.79 
2-day Diary 33 62.67 46.95 
2-day PSG 33 56.52 39.91 
    
Pre-Treatment    
SMW Group N Mean SD 
14-day Diary 27 71.33 42.04 
2-day Diary 27 79.96 80.61 
2-day PSG 27 61.83 36.95 
    
Post-Treatment    
CBT Group N Mean SD 
14-day Diary 33 20.55 18.23 
2-day Diaryd 33 29.82 34.18 
2-day PSG 33 53.87 38.91 
    
Post-Treatment    
SMW Group N Mean SD 
14-day Diary 27 54.30 39.71 
2-day Diary 27 74.04 67.43 
2-day PSG 27 59.77 41.32 
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Figure 5. Discrepancy between Subjective and Objective Measures of Wake Time After  
     Sleep Onset by Group at Pre- and Post-Treatment 
 
 
 
 
 Sleep efficiency is obtained by dividing total sleep time by total time in bed.  Total 
sleep time, in turn, is obtained by subtracting three separate variables from total time in bed: 
sleep latency time, awake time after sleep onset, and time awake in the morning prior to 
getting out of bed (early morning awakening).  Thus, it is possible to calculate what 
percentage of the discrepancy in sleep efficiency was attributed to each of these three 
variables.  Figure 6 illustrates the approximate percentage from each of these categories.    
 39 
 
WASO
Early Morning 
Awakening
Sleep Onset 
Latency
Figure 6. Percentage of Discrepancy in Sleep Efficiency at Pre-treatment Accounted for by 
     Sleep Onset Latency, Wake Time after Sleep Onset, and Early Morning    
     Awakening 
 
  
 Figure 7, below, illustrates the reduction in discrepancy after treatment with CBT-I 
and the change in distribution of the discrepancy in sleep efficiency from pre- to post-
treatment.  The CBT group demonstrated reduced discrepancy for all three parameters 
included but made particular improvements in their estimates of sleep onset latency. 
 
 
 
 
 
 
 
 
 
 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Distribution of Discrepancy in Sleep Efficiency at Pre- and Post-Treatment in the   
                CBT Group 
 
 
DBAS, GDS, and POMS scores as predictors of discrepancy 
 To test the third hypothesis, that Dysfunctional Beliefs and Attitudes about Sleep 
Scale (DBAS), Geriatric Depression Scale (GDS), and Profile of Mood States (POMS) 
scores would significantly predict the magnitude of negative discrepancy between subjective 
and objective measures at pre-treatment, multiple regression analysis was used.  DBAS total 
score, GDS total score, POMS total score, POMS tension subscale score, and the four DBAS 
subscale scores (perceived consequences of insomnia, worry/helplessness about insomnia, 
sleep expectations, medication) were entered as independent variables and average 
discrepancy in sleep efficiency at pre-treatment was included as the dependent variable. 
Because there was no clear a priori hypothesis about the order of the predictors, they were 
entered simultaneously into a single block.   
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 Prior to the analysis, statistical assumptions were checked, including normality, 
linearity, multicollinearity, and homoscedasticity.  Univariate and multivariate outliers were 
identified using mahalanobis distance and by examining boxplots.  No values were so 
extreme as to be assumed that they were thought to not be real values of the population and 
thus all cases were included in the analysis.  Normality was assessed by examining skewness 
and kurtosis statistics.  Due to high positive skew observed for POMS total score, POMS 
tension scale, and average discrepancy, square root transformations were applied to these 
variables.  The residuals scatterplot was eyeballed for linearity and due to the linear 
relationship observed between the data points, this assumption was determined to be met.  
Multicollinearity was examined prior to the analysis by running bivariate correlations 
between the variables.  Correlation coefficients were greater than .7 for DBAS total score and 
the four DBAS subscales so the subscale scores were subsequently removed from the 
analysis.  Finally, homoscedasticity was assessed by examining the residuals scatterplot.  The 
band enclosing the residual data points appeared approximately equal in width at all values of 
the dependent variable, indicating no violation of the assumption.   
 Results of the multiple regression show that the model was nonsignificant (p =.33) 
and none of the independent variables, individually, were significant predictors of the 
average discrepancy between measures of sleep efficiency at baseline (all ps > .09).  This 
result failed to support the third hypothesis. 
Change in DBAS score as a predictor of change in discrepancy 
 To test the fourth hypothesis, that change in DBAS score from pre- to post-treatment 
with CBT-I would predict change in the magnitude of the subjective/objective discrepancy, 
hierarchical multiple regression was used.  Change in DBAS score from pre- to post-
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treatment was entered as the primary independent variable and average change in the 
subjective/objective discrepancy for sleep efficiency from pre- to post-treatment was 
included as the dependent variable.  To control for change in sleep efficiency due to 
treatment effects (due to the known relationship between sleep efficiency and discrepancy 
illustrated in Figure 1), change in sleep efficiency from pre- to post-treatment as measured by 
polysomnography was entered into the first block of the model and change in DBAS score 
from pre- to post-treatment was entered into the second block.  
 Prior to the analysis, statistical assumptions of normality, linearity, multicollinearity, 
and homoscedasticity were checked.  Univariate and multivariate outliers were identified 
using mahalanobis distance and by examining boxplots.  No values were so extreme that they 
were thought to not be real values of the population and thus all cases were included in the 
analysis.  Normality was assessed by examining skewness and kurtosis statistics.  The change 
in sleep efficiency variable was slightly positively skewed; however, it was decided that 
transformation of this variable was not necessary.  The residuals scatterplot was eyeballed for 
linearity and due to the linear relationship observed between the data points, this assumption 
was determined to be met.  Multicollinearity was examined during the analysis using the 
Tolerance statistic.  The value of this statistic was sufficiently high to conclude that this 
assumption had been met.  Finally, homoscedasticity was assessed by examining the 
residuals scatterplot.  The band enclosing the residual data points appeared approximately 
equal in width at all values of the dependent variable, indicating no violation of the 
assumption.   
 The hierarchical multiple regression was first conducted using all cases to examine 
the predictors after eight weeks of either treatment.  Results of the regression show that when 
 43 
 
entered alone, change in sleep efficiency significantly predicted change in the 
subjective/objective discrepancy, F(1,57) = 5.22, p < .05; R2 = .085, as expected.   Eight point 
five percent (8.5%) of the variance in change in discrepancy could be predicted by change in 
sleep efficiency.  When change in DBAS score was added, it significantly improved the 
prediction, R2 change = .065, F(2,57) = 4.85, p < .05; R2 = .15.  When controlling for change 
in sleep efficiency from pre- to post-treatment, change in DBAS score significantly predicted 
6.5% of the variance in change in the subjective/objective discrepancy.  Together, the two 
independent variables significantly predicated a total of 15% of the variance in this variable 
(see Table 4).   
 
Table 4.  
Hierarchical Multiple Regression Analysis Summary for Change in Sleep Efficiency and 
Change in DBAS Score Predicting Change in the Subjective/Objective Discrepancy 
 
Variable B SEB ß R2 R2 change 
Step 1       .085 .085 
   Change in SE .467 .204 .292* 
    
   Constant .052 .018     
            
Step 2       .15 .065 
   Change in SE .424 .200 .265* 
 
  
   Change in 
   DBAS Score 
.003 .002 .256*     
   Constant .039 .019     
            
*p < .05 
  
 To assess change in sleep efficiency and change in DBAS score as predictors of 
change in the subjective/objective discrepancy specifically after treatment with CBT-I, the 
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hierarchical linear regression was next conducted using only CBT cases.  Results show that 
both change in sleep efficiency and change in DBAS score were not significant predictors of 
change in the subjective/objective discrepancy, (all ps > .31), failing to provide support for 
the fourth hypothesis. 
 Returning to the hierarchical regression using all cases, change in DBAS subscale 
scores were examined as predictors of change in the discrepancy for the purpose of 
identifying whether the endorsement of particular types of dysfunctional beliefs or attitudes 
about sleep relate more closely to change in misperception of one's sleep parameters.  
Change scores (differences observed between pre- and post-treatment) were calculated for 
each subscale (perceived consequences of insomnia, worry/helplessness about insomnia, 
sleep expectations, and medication).  When entered together into a model predicting change 
in the subjective/objective discrepancy, both the overall model and individual variables were 
nonsignificant (all ps > .43).   
Baseline discrepancy as a predictor of treatment response 
 To test the fifth hypothesis, that the size of the subjective/objective discrepancy prior 
to treatment with CBT-I would be a significant predictor of treatment response, hierarchical 
multiple regression was used.  Treatment response was measured as change in sleep 
efficiency assessed by sleep diary across two weeks at pre- and post-treatment.  Average 
discrepancy between measures of sleep efficiency at pre-treatment was entered as the 
primary independent variable along with age, number of medications, and number of medical 
conditions.  To control for baseline sleep efficiency (due to the known relationship between 
sleep efficiency and discrepancy illustrated in Figure 1), baseline sleep efficiency measured 
by polysomnography was entered into the first block of the model and the other variables 
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were entered into the second block.  Change in sleep efficiency was entered as the dependent 
variable.  Only CBT cases were included in the analysis. 
 Prior to the analysis, statistical assumptions were checked, including normality, 
linearity, multicollinearity, and homoscedasticity.  Univariate and multivariate outliers were 
identified using mahalanobis distance and by examining boxplots.  No values were so 
extreme that they were thought to not be real values of the population and thus all cases were 
included in the analysis.  Normality was assessed by examining skewness and kurtosis 
statistics.  Due to high positive skew observed for the discrepancy between measures of sleep 
efficiency at pre-treatment variable, a square root transformation was applied.  The residuals 
scatterplot was eyeballed for linearity and due to the linear relationship observed between the 
data points, this assumption was determined to be met.  Multicollinearity was examined 
during the analysis using the Tolerance statistic.  The value of this statistic was sufficiently 
high to conclude that this assumption had been met.  Finally, homoscedasticity was assessed 
by examining the residuals scatterplot.  The band enclosing the residual data points appeared 
approximately equal in width at all values of the dependent variable, indicating no violation 
of the assumption.   
 Results of the hierarchical multiple regression showed that discrepancy at pre-
treatment was found to be the only significant predictor of treatment response when 
controlling for baseline sleep efficiency, so the other predictors were subsequently removed 
from the model.  When entered alone, baseline sleep efficiency marginally significantly 
predicted treatment response, F(1,32) = 3.88, p =.058; R2 = .11.  When baseline discrepancy 
was added to the model, it significantly improved the prediction, R2 change = .207, F(2,32) = 
7.00, p < .01; R2 = .32.  When controlling for baseline sleep efficiency, baseline discrepancy 
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significantly predicted 20.7% of the variance in fourteen day treatment outcome.  Together, 
the two independent variables significantly predicated a total of 31.8% of the variance in this 
variable (see Table 5). 
 
Table 5. 
Hierarchical Multiple Regression Analysis Summary for Baseline Sleep Efficiency and 
Baseline Discrepancy Predicting Treatment Response 
 
Variable B SEB ß R2 R2 change 
Step 1       .111 .111 
   Baseline SE -.372 .189 -.334 
    
   Constant .453 .151     
            
Step 2       .318 .207 
   Baseline SE -.464 .171 -.416* 
 
  
   Baseline    
   Discrepancy 
.272 .090 .462*     
   Constant .456 .134     
            
       *p < .05 
 
Change in discrepancy as a predictor of treatment response 
To test the sixth hypothesis,  that change in the magnitude of the subjective/objective 
discrepancy from pre- to post-treatment would significantly predict treatment response to 
CBT-I, hierarchical multiple regression was used.  Treatment response was again measured 
as change in sleep efficiency assessed by sleep diary across two weeks at pre- and post-
treatment.  To control for baseline sleep efficiency (again, due to the known relationship 
between sleep efficiency and discrepancy illustrated in Figure 1), baseline sleep efficiency 
measured by polysomnography was entered into the first block of the model and change in 
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the discrepancy between subjective and objective measures of sleep efficiency from pre- to 
post-treatment was entered into the second block.  Change in sleep efficiency as measured by 
two-week sleep diary was entered as the dependent variable.  The analysis was conducted in 
CBT cases only. 
 Prior to the analysis, statistical assumptions were checked, including normality, 
linearity, multicollinearity, and homoscedasticity.  Univariate and multivariate outliers were 
identified using mahalanobis distance and by examining boxplots.  No values were so 
extreme that they were thought to not be real values of the population and thus all cases were 
included in the analysis.  Normality was assessed by examining skewness and kurtosis 
statistics.  Both variables (change in sleep efficiency and change in discrepancy) were 
slightly positively skewed; however, it was decided that it was not necessary to transform 
them.  The residuals scatterplot was eyeballed for linearity and due to the linear relationship 
observed between the data points, this assumption was determined to be met.  
Multicollinearity was examined during the analysis using the Tolerance statistic.  The value 
of this statistic was sufficiently high to conclude that this assumption had been met.  Finally, 
homoscedasticity was assessed by examining the residuals scatterplot.  The band enclosing 
the residual data points appeared approximately equal in width at all values of the dependent 
variable, indicating no violation of the assumption.   
 Results of the regression show that when entered alone, baseline sleep efficiency 
marginally significantly predicted treatment response, F(1,32) = 3.88, p =.058; R2 = .11  
When change in discrepancy was added to the model, it significantly improved the 
prediction, R2 change = .354, F(2,32) = 13.03, p < .001; R2 = .465.  When controlling for 
baseline sleep efficiency, change in discrepancy significantly predicted 35.4% of the variance 
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in fourteen day treatment outcome.  Together, the two independent variables significantly 
predicated a total of 46.5% of the variance in this variable, setting an upper limit of 53.5% of 
variance in two-week treatment outcome explained by actual changes in sleep quantity (see 
Table 6). 
 
Table 6. 
Hierarchical Multiple Regression Analysis Summary for Baseline Sleep Efficiency and 
Change in Discrepancy Predicting Treatment Response 
 
Variable B SEB ß R2 R2 change 
Step 1       .111 .111 
   Baseline SE -.372 .189 -.334 
    
   Constant .453 .151     
            
Step 2       .465 .354 
   Baseline SE -.418 .149 -.375* 
 
  
   Change in   
   Discrepancy 
.552 .124 .596**     
   Constant .448 .119     
            
      *p < .01 
      ** p < .001 
 
Comparison of sleep parameters on PSG nights versus non-PSG nights 
 To test the seventh hypothesis, that participants would sleep differently on PSG 
nights due to sensory intrusions, paired t-tests were used.  Pairs were created between two-
week sleep diary and two-night PSG variables for each parameter (SE, SOL, TST, WASO).  
Prior to the analysis, statistical assumptions of normality and homogeneity of variance were 
checked.  Normality was assessed by examining skewness and kurtosis statistics.  Due to 
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positive skew observed for sleep onset latency and wake time after sleep onset variables, 
both two-week and two-night variables were transformed.  Wake time after sleep onset 
variables were transformed using square root transformations and sleep onset latency 
variables were transformed using log transformation due to more severe skew.  Levene's test 
was used to assess homogeneity of variance and nonsignificant results for this preliminary 
analysis indicated no violation of this assumption.    
 Results of the paired t-tests show that no significant differences were observed 
between two-week and two-night averages for all parameters (all ps > .17), indicating that 
sleep behaviors on nights when participants are undergoing polysomnographic assessment do 
not look markedly different from normal nights of sleep.  This finding fails to provide 
support for the seventh hypothesis. 
Discussion 
 The primary purpose of this secondary analysis was to further explore the discrepancy 
between subjective and objective measures of insomnia as a phenomenon characteristic of 
those with insomnia by assessing its presence in a sample of older adults with comorbid 
insomnia enrolled in a treatment study.  This study also sought to determine how the 
discrepancy changes after treatment with Cognitive-Behavioral Therapy for Insomnia as 
compared to a Stress Management and Wellness control treatment.  Additionally, this study 
sought to examine predictors of the discrepancy as well as the relationship between 
discrepancy and treatment response and between discrepancy and dysfunctional beliefs and 
attitudes about sleep.   
 The paired t-test analyses show that, as hypothesized, there exists a significant 
discrepancy between subjective and objective measures of insomnia.  Table 2 illustrates that 
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participants underestimated sleep efficiency and total sleep time and overestimated sleep 
onset latency at baseline.  These findings are consistent with the results of previous studies, 
which found that many individuals with insomnia report more subjective sleep disturbance 
than what objective measures corroborate (Carskadon et al., 1976; Frankel et al., 1976).  
However, the difference between subjective and objective measures of wake time after sleep 
onset was not significant at baseline.  This finding suggests that participants in this study, 
overall, were accurate in their perceptions of this parameter before intervention.  In line with 
what other studies from the literature have found, a number of participants in this study 
exhibited a positive bias when estimating their sleep, reporting fewer sleep complaints than 
objective measures showed (Edinger & Fins, 1995; Carskadon et al, 1976).  Out of the 60 
two-day estimations made at pre-treatment, 4 showed positive bias (> 5%), 35 showed 
negative bias (> 5%), and 21 were neutral (within ±5%).  Because this particular study 
sought to focus on the negative rather than positive bias, correlates and predictors of this 
positive bias were not examined.  It is recommended that this positive form of bias be further 
explored in future studies. 
 By examining the discrepancy for individual sleep parameters, a picture emerges of 
which parameters were most affected by misperception in this sample and which parameters 
were most affected by CBT-I intervention.  At baseline, as seen in Figure 6, more than 50% 
of the discrepancy in total sleep time could be accounted for by discrepancy in sleep onset 
latency.  This indicates that participants most significantly misperceived the length of time it 
took them to fall asleep at night.  Following treatment, the CBT group was observed to have 
significantly diminished discrepancy as compared to SMW, as illustrated in Figures 2-5.  As 
Figure 7 illustrates, the CBT group made a particularly marked improvement in accuracy of 
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perception of sleep onset latency, reducing discrepancy by an average of 32 minutes.  
Although this group started out with an average discrepancy more than ten minutes higher 
than the average for the SMW group, they reduced the discrepancy to only 3 minutes after 
treatment.  This was 13 minutes less than the post-treatment discrepancy observed for the 
SMW group.  For sleep efficiency, sleep onset latency, and total sleep time, participants’ 
subjective reports of sleep were not significantly different from objective measures after 
treatment with CBT, demonstrating that CBT treatment basically eliminated discrepancy in 
these domains.  However, there was an increase in discrepancy observed for the parameter of 
wake time after sleep onset.   For this parameter, there was no significant discrepancy at 
baseline but the CBT group moved to significant underestimation of awakening time at post-
treatment.   
It is difficult to interpret why this shift to significant underestimation occurred for this 
sleep parameter, in particular.  It may be that wake time after sleep onset is especially 
difficult to estimate because it occurs after sleep onset and before a final awakening and 
often involves keeping track of multiple periods of arousal.  Despite the relatively low 
discrepancy observed for this parameter at pre-treatment  in this study, it could be that it is 
particularly vulnerable to a placebo effect based on positive expectancy.  The purpose of the 
placebo treatment group was to control for such effects, but it is not a perfect substitute for a 
true treatment group.  Participants in the CBT group may have still picked up on some type 
of additional positive expectancy while in treatment that resulted in a greater expectation for 
improvements in sleep in this group.  This bias could be the result of inadvertent influence by 
study staff or clinicians or differences in plausibility and expectancy that occurred after these 
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variables were measured and shown to be the same after the first two sessions (Rybarczyk et 
al., 2005).   
 As illustrated in Figure 1, lower sleep efficiency at baseline was associated with 
higher discrepancy due to the fact that more awakening time leads to more opportunities to 
misjudge one's sleep.  Following this logic, it could be suggested that the observed 
improvement in discrepancy after treatment with CBT-I is the result of an improvement in 
sleep efficiency.  However, because objective measures of sleep efficiency were not observed 
to change significantly from pre- to post-treatment, this is not a plausible explanation.  This 
fact suggests that CBT had an effect on sleep perception, resulting in more accurate 
subjective reporting of sleep compared to the SMW treatment condition.   
 Multiple regression results established that, contrary to the third hypothesis, negative 
mood, anxiety, and dysfunctional beliefs and attitudes about sleep were not significant 
predictors of the magnitude of the discrepancy at baseline.  This finding goes against what 
has been established in the literature about mood and anxiety factors as correlates of the 
subjective/objective discrepancy (Rosa & Bonnet, 2000; Edinger et al., 2000) and what was 
hypothesized in terms of a relationship between dysfunctional cognitions and sleep 
misperception.  It is possible that the exclusion of those participants with a history of a major 
psychiatric condition contributed to this lack of significant results; however, similar 
exclusion criteria existed in the previously conducted studies.  Another possibility is that the 
small sample size included in this study may have limited statistical power, thereby 
producing a false negative result.  Regardless, it is unknown from the results of this study 
what types of psychological characteristics are associated with the subjective/objective 
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discrepancy before treatment.  More research will need to be conducted to identify clear 
correlates of this phenomenon.   
 Although DBAS score was not a significant predictor of the subjective/objective 
discrepancy at baseline, results of the hierarchical multiple regression using all subjects 
showed that change in DBAS score from pre- to post-treatment was a significant predictor of 
change in the discrepancy.  This finding provides evidence for a relationship between 
dysfunctional beliefs about sleep and the subjective/objective discrepancy and suggests that a 
reduction in these maladaptive thinking patterns correlates with a reduction in negative sleep 
misperception.  Examination of the specific dysfunctional beliefs one might endorse through 
an additional hierarchical regression with the DBAS subscale scores failed to provide 
evidence that endorsement of a particular type of belief (e.g. worry about the consequences 
of insomnia) is associated with change in the discrepancy more so than others.  Results of the 
hierarchical regression using only CBT cases were nonsignificant, indicating that change in 
DBAS score did not predict change in the subjective/objective discrepancy for the CBT 
group.  However, as shown in Figure 8, below, those participants in the CBT group who 
showed particularly high discrepancy between subjective and objective measures of sleep 
efficiency at baseline showed greater reduction in dysfunctional beliefs and attitudes about 
sleep as compared to those in the CBT group with less discrepancy or those in the SMW 
group. 
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Figure 8. Change in DBAS Score from Pre- to Post-Treatment, by Amount of Baseline 
 Discrepancy and/or Treatment Group 
 
This finding provides evidence to suggest that misperception, as one form of dysfunctional 
belief, is improved with CBT and suggests that the lack of significant effect in the CBT 
group may be due to insufficient statistical power due to small sample size (n = 33) rather 
than a true lack of association between these variables.   
 Results of the hierarchical multiple regression analysis examining the relationship 
between baseline discrepancy and treatment response provide support for the fifth hypothesis 
and suggest that individuals who enter treatment with high subjective/objective discrepancy 
show significantly better treatment response to CBT-I.  This finding parallels those of 
previous studies reporting a significant relationship between treatment response to CBT and 
high endorsement of dysfunctional beliefs and attitudes about sleep (Espie, 1999; Espie et al., 
2001).  Specifically, Espie and colleagues (2001) found that negative beliefs about the long 
term effects of insomnia prior to treatment were associated with positive treatment response 
and interpreted this to mean that sleep related thinking errors could be a mediating factor for 
treatment effects as supported by the fact that DBAS scores changed after CBT intervention. 
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The results of Edinger and colleagues’ 2008 study indicated that patients with a high degree 
of unhelpful sleep cognitions were more likely to benefit from CBT-I than patients who had 
lower levels of maladaptive sleep related thoughts.  The authors concluded that pre-therapy 
sleep cognitions could be useful in identifying which patients would benefit most from CBT-
I treatment.  If misperception can be conceptualized as a form of dysfunctional belief not 
captured by the DBAS scale, the results of the current study suggest that high 
subjective/objective discrepancy prior to treatment may be another useful tool for identifying 
which patients should be referred for CBT-I.  The fact that high pre-treatment discrepancy 
was predictive of positive treatment response in this sample also identifies misperception as 
an important target for treatment.  
 Change in discrepancy from pre- to post-treatment was also found to be a significant 
predictor of treatment response to CBT-I when controlling for baseline sleep efficiency, 
providing support for the sixth hypothesis.  Results of the hierarchical multiple regression tell 
us that 35.4% of change in fourteen day treatment outcome can be accounted for by 
improvement in the subjective/objective discrepancy during the two PSG nights; however, 
64.6% of treatment response has yet to be explained.  This remaining portion could 
presumably be accounted for by factors other than changed sleep perception, including “real” 
changes in sleep.  Additionally, the diminished discrepancy between subjective and objective 
measures of insomnia on PSG nights does not account for all of the significant change 
observed at post-treatment using two-week sleep diary measures.  Polysomnographic 
measures of sleep efficiency did not even change by a full percentage point after treatment 
with CBT; however, the two-week sleep diary measures indicate an improvement of nearly 
16%.  This implies that the two days may not be fully representative of two weeks of sleep 
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and other factors may be involved.   Further research is needed in order to better understand 
this result. 
 Results of paired t-tests between two-week sleep diary and the sleep diary for the two 
PSG-nights for each parameter (sleep efficiency, sleep onset latency, total sleep time, and 
wake time after sleep onset) showed that sleep does not look markedly different on nights 
when participants were undergoing home polysomnographic assessment relative to normal 
nights.  Despite the presence of recording equipment, including leads connected to various 
parts of the body and head, participants did not report longer sleep latencies, more nighttime 
awakenings, or reduced total sleep time.  Despite what was implied by the previous analysis, 
this suggests that two-night averages of sleep patterns in this study were representative of 
participants' typical sleep and also provides evidence for the clinical utility of home 
polysomnographic assessment.  Had participants shown evidence of altered sleep patterns, 
perhaps due to truncating sleep by removing uncomfortable PSG equipment in the morning 
hours, this would indicate a concern regarding the accuracy of data collected using the 
method of objective assessment.  It would also threaten the generalizability of sleep data 
from these nights.   
It has been established that many insomniacs sleep differently in the lab than they do 
in their home environment due to the absence of cues that facilitate arousal (Edinger et al., 
2001).  The results of this study provide evidence to suggest that home polysomnography 
may have the potential to capture a more accurate picture of an individual's typical sleep 
behavior while also reducing costs to the patient.  This is an important finding given the fact 
that technological advances in PSG will eventually lead to a more widespread use of home 
assessment of sleep due to the lower costs.  If cost becomes low enough and the feedback 
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regarding sleep state misperception is shown to improve CBT-I treatment response, PSG may 
even be justified as a tool for assessment in all cases of insomnia.    
 In summary, this study sought to more closely examine the discrepancy between 
subjective and objective measures of insomnia, which has been established as a common 
characteristic of many insomniacs.  After assessing discrepancy between sleep diary and 
polysomnographic measures of four sleep parameters in a sample of older adults with 
comorbid insomnia, the results of this study show that many individuals reported subjective 
complaints of sleep disturbance that were significantly more severe than what objective 
measures showed.  Negative mood, anxiety, and high endorsement of dysfunctional beliefs 
and attitudes about sleep were not significant predictors of this discrepancy before treatment, 
as was hypothesized.  However, change in dysfunctional beliefs about sleep did significantly 
predict change in the discrepancy, providing evidence to support that misperception may be 
one form of dysfunctional belief.  Assessing the magnitude of the subjective/objective 
discrepancy prior to treatment was identified as a potentially useful tool for recognizing 
patients who are likely to respond well to treatment with CBT-I after high discrepancy was 
found to be predictive of positive treatment response.  An additional finding suggests that a 
reduction in misperception rather than actual sleep changes accounts for a portion of the 
treatment response observed after CBT-I.   Finally, home polysomnographic assessment was 
not shown to significantly alter normal sleep behaviors. 
One observation of the data regarding discrepancy in this study that is not highlighted 
in other studies to date is that estimates of sleep onset latency constituted the highest portion 
of both initial discrepancy and change in discrepancy after CBT.  This suggests that the 
initial transition from wake to sleep is where the highest risk for discrepancy occurs when 
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recalling sleep the next day, even though this does not constitute the largest portion of self-
reported insomnia in this population (30% of awake time was attributed to latency) and other 
populations (an average of 44% of awake time was attributed to latency in a meta-analysis by 
Smith et al., 2002).  To some extent, this is a logical finding because it is the point of time 
furthest away from when the diary is completed.  Additionally, stage 1 sleep is often difficult 
for an individual to detect.  What an individual reports to be an extended sleep onset latency 
may actually be light, stage 1 sleep interrupted by an arousal or awakening.  Future studies 
should analyze whether the percentage of stage 1 sleep is maintained longer in the initial 
period of sleep in those who tend to overestimate the severity of their sleep disturbance.  An 
additional treatment implication from this finding is that CBT-I intervention should attempt 
to redirect awareness by emphasizing the difficulty that individuals with sleep problems have 
in assessing when the transition occurred.  It also supports the possibility that reductions in 
anxiety at bedtime will reduce the perceived salience of that period of time during the night, 
therefore reducing its perceived length.   
Perhaps the most intriguing finding from this study is the significant reduction in 
discrepancy observed after treatment with CBT-I.  This suggests that CBT may not only 
work to diminish maladaptive thinking patterns related to perceived consequences of 
insomnia, worry about insomnia, sleep expectations, and medication, but may also reduce the 
misperception of sleep.  In fact, using variance data from regression analyses, the increase in 
accuracy of sleep perception accounted for approximately 32% of the change that occurred in 
sleep at post-treatment.  This finding raises questions not emphasized in the literature thus far 
about the extent to which improvements in insomnia are largely “real” changes in sleep or 
merely perceived changes.  A number of studies have demonstrated corroborating evidence 
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for improvements in sleep after treatment but these changes are frequently of a much lower 
magnitude than self-reported changes occurring over a larger window of time than one or two 
nights of PSG (Morin et al., 2006).  Previous interpretations of this discrepancy have been 
attributed to differences between home sleep and laboratory sleep (Edinger et al., 2001) and 
have not been subjected to the same type of analyses performed in this study to our 
knowledge.  Post-hoc analyses using the same methods employed in this study by other 
investigators who reported both self-report and PSG outcomes from CBT-I would shed 
further light on this issue and be a valuable contribution to the literature.    
 Taken together, the findings of this study have implications for our understanding of 
how CBT-I works and for the discussion of how insomnia is best defined.  The significant 
improvement observed in maladaptive thinking and misperception after treatment with CBT 
in this study suggests that for those with subjective reports of sleep disturbance that are not 
objectively corroborated, CBT might work by improving the accuracy of sleep perception 
more so than changing physiological sleep patterns.  From this idea, the question emerges of 
CBT's effectiveness for those who do present with objectively disturbed sleep.  It is 
reasonable to wonder whether there should in fact be "subjective" versus "objective" 
subtypes of insomnia, as the literature has debated (Edinger & Krystal, 2003).  Subjective 
insomnia may be an entity distinct from insomnia that is objectively corroborated.   Different 
underlying factors for these two subtypes would necessitate different approaches to treatment 
in order to produce optimal outcomes.  Alternatively, the findings of this study may provide 
support for the utility of a "sleep-state misperception" subtype of insomnia, which is 
recognized as a separate diagnosis by the International Classification of Sleep Disorders 
(AASM, 2005).  More research is needed to further explore this possibility.   
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 Despite its strengths, this study was subject to multiple limitations that must be 
considered.  Perhaps the most significant limitation is the absence of analysis of sleep stages 
or depth of sleep using PSG measures.  For the present study it was decided that the focus 
would be on discrepancy between perception of being asleep and documented sleep of any 
type.  A more refined analysis would take into account the depth of sleep to determine if 
individuals who perceive themselves to be awake are actually experiencing lower quality or 
less restorative sleep relative to those who are more accurate in their sleep estimates.  This 
has been suggested by previous investigators (Mendelson, James, Garnett, Sack, & 
Rosenthal, 1986) along with the possibility that the disorder of “sleep-state misperception” is 
an inaccurate and pejorative term.  Even though some research has failed in its attempt to 
find EEG abnormalities or lighter sleep in these individuals (Mendelson et al., 1986) it is 
possible that our EEG scoring methods are not sophisticated enough to detect subtle but true 
physiological differences in this population.   Power density analysis offers some potential 
for detecting such differences in future studies (Merica, Blois, & Gaillard, 1998).   If such 
were the case, then CBT changes may in fact be leading to subtle improvements in sleep 
physiology, resulting in an accurate perception of improved sleep.  As such, future analyses 
of the current database would be well advised to include analyses of changes in sleep staging 
or other EEG changes that may have occurred in the negative bias group.   
A second limitation is the small sample size (n = 60) utilized in this study.  
Particularly in the case of the two analyses involving only the CBT group (n = 33), this small 
number of data points may have limited the ability to find significant effects that would have 
emerged from a larger sample.  The multiple regression predicting change in the magnitude 
of the discrepancy was significant when all participants were included in the analysis; 
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however, when the analysis was conducted in the CBT group alone, the results did not reach 
significance.  The inherent variability of sleep parameters must also be considered.  Sleep 
onset latency and wake time after sleep onset, in particular, vary significantly both night-to-
night and between individuals.  As a result of this fact, small sample size in this study led to 
the appearance of extreme values and data that did not fit a normal distribution.  Extreme 
values that did not appear to be real values of the population were excluded from analyses; 
however, many extreme values were not excluded due to the fact that significant variation is 
not unexpected with a sample of individuals with chronic insomnia.  Many variables included 
in the primary analyses were found to be skewed and kurtotic and were subsequently 
transformed in order to meet the assumptions required by parametric tests.  The necessary 
steps were taken to minimize non-normality; however, some minimal skewness and kurtosis 
remained for some variables.  With a larger sample size, normality would pose less of an 
issue and the significance and robustness of the findings would have likely been improved.   
A third limitation is that of missing sleep diary or polysomnography data in this 
study.  Seventeen participants were dropped from the parent study due to the absence of diary 
or polysomnography data at either pre- or post-treatment.  It is possible that this attrition was 
non-random and was, in fact, more common among those participants who were better at 
estimating their sleep.  Additionally, eleven participants were missing a single night of either 
diary or PSG data due to data entry error, PSG technology failure, or errors in participant 
reporting.  Rather than excluding these participants, it was decided that these missing cells 
would be filled with data from the previous or subsequent night of sleep.  While this 
prevented potential problems due to an even more diminished sample size, sleep parameters 
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at individual time points were captured by a single night of assessment rather than averaged 
across two nights, which may limit how representative the data was.   
 A fourth limitation of the current study is the lack of direct personality measures that 
may have been useful in determining predictors of the subjective/objective discrepancy.  
Previous research has suggested that personality factors may be correlated with the tendency 
to misperceive disturbances in sleep (e.g. neuroticism, hypochondriasis; Corsey et al., 1975; 
Kales et al., 1976; Tan et al., 1984); however, this study left these factors unexplored.   
 A fifth limitation involves the level of insomnia severity.  In order to be included in 
the original study, a potential participant had to have had at least three episodes of insomnia 
per week for at least 6 months, and had to have suffered from daytime consequences of 
insomnia such as fatigue or trouble concentrating.  Individuals with fewer episodes of 
insomnia or shorter duration of complaints were excluded from participation.  Because of 
this, the individuals who participated in this study suffered from severe insomnia which 
could limit the generalizability of the study.  It is possible that the subjective/objective 
discrepancy would manifest itself differently, relate differently to dysfunctional beliefs, or 
respond differently to CBT-I in a less specific or severe population.   
A final flaw in the study design was that individuals in the CBT group kept a sleep 
diary throughout treatment, whereas the SMW group only engaged in required self-
monitoring during set periods of time (two weeks) at pre-treatment and post-treatment.  This 
means that one alternative explanation for the findings is that the CBT-I treatment per se was 
not the factor that led to improved accuracy in sleep estimation but, instead, it was simply 
caused by what some researchers have termed a "diary-keeping effect" (Franklin, 1981; 
Engel-Friedman, Bootzin, Hazelwood, & Tsao, 1992, Morin, 1993).  Future studies should 
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control for this threat to internal validity by having control participants also keep a weekly 
diary during the treatment period.     
 This study contributes to the existing literature by identifying the subjective/objective 
discrepancy in a unique sample of older adults with comorbid insomnia and providing 
evidence to suggest that this discrepancy may be a potential factor in a favorable treatment 
response to CBT.  Despite what is offered by the results of this study, there is more to be 
learned about the subjective/objective discrepancy.  Several directions for future research can 
be suggested with this objective in mind.  As mentioned above, a major limitation of the 
current study was the small sample size.  The literature would benefit from studies including 
a substantial number of participants to account for the potential for missing data and the 
variability of sleep patterns that increases the likelihood of non-normality.  An additional 
limitation of this study was the lack of personality variables when examining predictors of 
the subjective/objective discrepancy.  Future studies should consider neuroticism, 
hypochondriasis, or other personality factors as potential correlates of sleep misperception. 
 Additionally, physiological correlates identified in previous studies (e.g. EEG over-
activation or overall hyperarousal) should be considered in future research endeavors to 
uncover more about their hypothesized relationship to misperception of sleep.  As mentioned 
previously, future studies should also take into account the depth of sleep to determine if 
individuals who perceive themselves to be awake are actually experiencing lower quality or 
less restorative sleep relative to those who are more accurate in their sleep estimates.  
Another important future direction is to examine not only "negative bias," or the tendency to 
misperceive sleep as more disturbed than what objective measures show, but to examine 
"positive bias," as well.  The current study did not consider this phenomenon but future 
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research should examine correlates and predictors of this tendency and could examine how 
those with a positive bias respond to CBT.  A final idea for future research, in consideration 
of the proposed "subjective" and "objective" subtypes of insomnia mentioned previously, is 
to conduct a comparison of individuals fitting these classifications to determine if different 
variations of CBT-I are more or less successful for the different forms of insomnia.  This 
would improve our understanding of whether some components of CBT-I are most essential 
for the treatment of subtypes of insomnia in order to improve treatment efficiency and 
thereby reduce cost.  This would also contribute to the ongoing discussion of how insomnia 
is best defined.   
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SLEEP DIARY Date:        
         
Name: 10/9        
 Example        
 
1.  Yesterday, I napped from ___ to ___ (note the times of all naps). 
 
1:50 to 
2:30 p.m. 
 
       
 
2.  Yesterday, I took ___ mg of medication and/or ___ oz of ___ 
alcohol as a sleep aid. 
Ambien 
5 mg 
       
 
3.  Last night, I went to bed and turned the lights off at ___ o’clock. 
 
11:15 
 
 
       
 
4.  After turning the lights out, I fell asleep in ___ minutes. 
 
 
40 min 
 
 
       
 
5.  My sleep was interrupted ___ times (specify number of  
nighttime awakenings). 
 
3 
 
 
       
 
6.  My sleep was interrupted for ___ minutes (specify duration of 
each awakening). 
10 
5 
45 
 
       
 
7.  This morning, I woke up at ___ o’clock (note time of last 
awakening). 
 
6:15 
 
 
       
 
8.  This morning, I got out of bed at ___ o’clock (specify the time). 
 
6:40 
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